Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study - Concepedia

Concepedia

Publication | Closed Access

Efficacy and Safety of KRAS G12C Inhibitor IBI351 Monotherapy in Patients With Advanced NSCLC: Results From a Phase 2 Pivotal Study

33

Citations

21

References

2024

Year

Qing Zhou, Xiangjiao Meng, Longhua Sun, Dingzhi Huang, Nong Yang, Y. Yu, Mingfang Zhao, Wu Zhuang, Renhua Guo, Yi Fan Hu,

Journal of Thoracic Oncology

Advanced NsclcOncologyMedicineMetronomic TherapyClinical TrialsPivotal StudyPharmacotherapyPhase 2PharmacologyNovel Therapy

References

	Year	Citations

Page 1

Page 1